Travere Therapeutics Inc
For the period ended May 15, 2025. Filed Apr 1, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 15, 2025 · Filed Apr 1, 2025
Contents
Compensation Program Highlights
Pay for Performance/At Risk Pay
A significant portion of our CEO’s and other executive officers’ compensation is at risk; this includes cash incentives, stock options and vesting of previously granted performance restricted stock units (“PSUs”).
Independent Compensation Consultant and Analysis
The Compensation Committee engages an independent compensation consultant to analyze the competitive landscape and make recommendations regarding the compensation of our executive officers.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.